FDA Clears Israeli-Developed Standing Robotic Wheelchair UPnRIDE For US Distribution
UPnRIDE Robotics announced on Thursday that the US Food and Drug Administration (FDA) has cleared its Robotic Standing Wheelchair for marketing and use across the United States. The UPnRIDE will become available to wheelchair users and the elderly in the US, the Israeli company said.
The FDA gave UPnRIDE initial clearance in September. The device provides users with safe and functional mobility in a standing position in almost any environment, indoors and outdoors, the company says. It is suitable for most wheelchair users, including paraplegics, quadriplegics, the elderly and people suffering from MS, ALS, CP, stroke or TBI.
Read More: No Camels